Literature DB >> 9679666

Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidence.

R Buzzetti1, C C Quattrocchi, L Nisticò.   

Abstract

A combination of genetic and environmental factors is most likely the cause of Type 1 diabetes. Results from twin data, familial clustering of the disease and difference in incidence according to ethnicity infer the presence of specific disease genes. The genetic component of Type 1 diabetes cannot be classified according to a classical model of inheritance but is due to an interaction between different genes and environmental factors. The major genes are within the HLA region that are responsible for 40% of the genetic susceptibility, although other genes are important (non-HLA genes). To date, more than 10 specific loci have been localized on different chromosomes. The gene involved has been characterized only for two of such loci, IDDM1 and IDDM2, while in the other cases the presence of some susceptibility genes can be envisaged and their identification represents the goal of genetic research in coming years. Fine mapping of the loci will certainly increase our understanding of the genetics of Type 1 diabetes; the limitation in detecting some of the remaining genes by linkage studies can be overcome by association studies. That is possible via the collection of a large number of affected families (over 1000) in homogeneous populations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679666     DOI: 10.1002/(sici)1099-0895(199806)14:2<111::aid-dmr211>3.0.co;2-2

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN: 0742-4221


  12 in total

Review 1.  In vivo imaging of insulitis in autoimmune diabetes.

Authors:  A Signore; M Chianelli; M G Parisella; G Capriotti; P Giacalone; G Di Leve; R Barone
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 2.  Early induction of type 1 diabetes.

Authors:  M I Hawa; R D Leslie
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

3.  The incidence and prevalence of type-1 diabetes mellitus.

Authors:  Sebastian A Peter; Rebecca Johnson; Charles Taylor; Andrea Hanna; Patrick Roberts; Percival McNeil; Beverley Archer; Corrine SinQuee; Paul Roberts
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

4.  Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.

Authors:  T P Astill; R J Ellis; S Arif; T I M Tree; M Peakman
Journal:  Diabetologia       Date:  2003-04-09       Impact factor: 10.122

Review 5.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

Review 6.  Molecular targeting of pancreatic disorders.

Authors:  Kiichi Tamada; Xiao-Ping Wang; F Charles Brunicardi
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

7.  HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.

Authors:  Richard J Ellis; Ruben Varela-Calvino; Timothy I M Tree; Mark Peakman
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

8.  Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16.

Authors:  E Cabrera-Rode; L Sarmiento; C Tiberti; G Molina; J Barrios; D Hernández; O Díaz-Horta; U Di Mario
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

9.  The ethics of type 1 diabetes prediction and prevention research.

Authors:  Lainie Friedman Ross
Journal:  Theor Med Bioeth       Date:  2003

10.  Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation.

Authors:  Krystallenia I Alexandraki; Christina Piperi; Panayiotis D Ziakas; Nikolaos V Apostolopoulos; Konstantinos Makrilakis; Vassiliki Syriou; Evanthia Diamanti-Kandarakis; Gregory Kaltsas; Anastasios Kalofoutis
Journal:  J Clin Immunol       Date:  2008-01-26       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.